| Cat. No. |
Product Name |
Information |
| PC-22395 |
Tafbromin
TAF1(2) inhibitor
|
Tafbromin is a selective inhibitor of TAF1 bromodomain by binding to the second bromodomain (TAF1(2)) with KD of 260 nM, inhibits Hh pathway-dependent osteoblast differentiation. |
| PC-21341 |
PFI-6
MLLT1/3 ligand
|
PFI-6 is a selective small-molecule chemical probe inhibitor for the YEATS domain of MLLT1 and MLLT3 with IC50 of 140 nM and 160 nM, respectively. |
| PC-21302 |
SGC-CBP30
CBP/p300 inhibitor
|
SGC-CBP30 is a potent and highly selective CBP/p300 bromodomain inhibitor with Kd values of 21/32 nM, respectively. |
| PC-21072 |
IV-255
BRG1 bromodomain inhibitor
|
IV-255 is a next-generation selective inhibitor of BRG1 bromodomain, inhibits SWI/SNF complex and enhances DNA damage and cell death in glioblastoma. |
| PC-20838 |
BBC1115
BET inhibitor
|
BBC1115 is a novel chemotype inhibitor of bromodomain and extra-terminal motif (BET) proteins, displays broad binding across BDs of BET proteins. |
| PC-20573 |
Birabresib
BET bromodomain inhibitor
|
Birabresib (OTX-015) is a potent, competitive inhibitor of BET bromodomain BRD2, BRD3, and BRD4 with EC50 of 10-19 nM, inhibits binding of BRD2, BRD3, and BRD4 to acetylated histone H4 (AcH4) with IC50 of 92-112 nM. |
| PC-20463 |
BI 1702135
SMARCA2 binder
|
BI 1702135 (Compound 4) is a potent SMARCA2 binder for targeted protein degradation (PROTAC) design as BI 1810284 (ACBI2, Cat. PC-20464). |
| PC-20343 |
FHT-2344
BRG1/BRM inhibitor
|
FHT-2344 (FHT2344) is a potent, selective inhibitor of SMARCA4 and SMARCA2 (BRG1 and BRM) with IC50 of 26 and 13 nM respectively, the ATPase component of the BAF complex. |
| PC-20342 |
FHT-1015
BRG1/BRM inhibitor
|
FHT-1015 (FHT1015) is a potent, selective inhibitor of SMARCA4 and SMARCA2 (BRG1 and BRM) with IC50 of 4 and 5 nM respectively, the ATPase component of the BAF complex. |
| PC-20312 |
SJ1461
BET inhibitor
|
SJ1461 (SJ-1461) is a potent and orally bioavailable BET inhibitor with IC50 of 6.8/0.2 nM for BRD4 BD1/BD2, and 1.3/0.1 nM for BRD2 BD1/BD2, respectively. |
| PC-20181 |
XS018661
ENL/AF9 YEATS inhibitor
|
XS018661 (XS 018661) is a potent first-in-class inhibitor of the YEATS domains of ENL and AF9 with Kd of 754/523 nM, IC50 of 1.6/3.0 uM, respectively. |
| PC-20178 |
L-Moses dihydrochloride
PCAF/KAT2B inhibitor
|
L-Moses dihydrochloride (L-45) is a potent, selective, and cell-active PCAF (KAT2B) bromodomain inhibitor with Ki of 47 nM in HTRF assays, >4,500-fold selectivity over BRD4. |
